99 related articles for article (PubMed ID: 21137081)
21. Identification of epitopes of trichosanthin by phage peptide library.
Zhu Z; Ming Y; Sun B
Biochem Biophys Res Commun; 2001 Apr; 282(4):921-7. PubMed ID: 11352639
[TBL] [Abstract][Full Text] [Related]
22. Mapping of the ICOS binding surface of murine B7h using an unbiased, cellular library of B7h mutants created by cyclical packaging rescue.
Bakkour S; Sha WC
J Immunol Methods; 2008 Mar; 332(1-2):151-61. PubMed ID: 18294651
[TBL] [Abstract][Full Text] [Related]
23. Construction of high-complexity combinatorial phage display peptide libraries.
Noren KA; Noren CJ
Methods; 2001 Feb; 23(2):169-78. PubMed ID: 11181036
[TBL] [Abstract][Full Text] [Related]
24. Phage display: concept, innovations, applications and future.
Pande J; Szewczyk MM; Grover AK
Biotechnol Adv; 2010; 28(6):849-58. PubMed ID: 20659548
[TBL] [Abstract][Full Text] [Related]
25. Identification of target membrane proteins as detected by phage antibodies.
Geuijen CA; Bakker AQ; de Kruif J
Methods Mol Biol; 2009; 528():141-58. PubMed ID: 19153691
[TBL] [Abstract][Full Text] [Related]
26. Development of an antibody proteomics system using a phage antibody library for efficient screening of biomarker proteins.
Imai S; Nagano K; Yoshida Y; Okamura T; Yamashita T; Abe Y; Yoshikawa T; Yoshioka Y; Kamada H; Mukai Y; Nakagawa S; Tsutsumi Y; Tsunoda S
Biomaterials; 2011 Jan; 32(1):162-9. PubMed ID: 20933274
[TBL] [Abstract][Full Text] [Related]
27. Peptide-mediated targeting to tumor blood vessels of lung cancer for drug delivery.
Lee TY; Lin CT; Kuo SY; Chang DK; Wu HC
Cancer Res; 2007 Nov; 67(22):10958-65. PubMed ID: 18006841
[TBL] [Abstract][Full Text] [Related]
28. Phage display derived human monoclonal antibodies isolated by binding to the surface of live primary breast cancer cells recognize GRP78.
Jakobsen CG; Rasmussen N; Laenkholm AV; Ditzel HJ
Cancer Res; 2007 Oct; 67(19):9507-17. PubMed ID: 17909061
[TBL] [Abstract][Full Text] [Related]
29. Mapping tumor vascular diversity by screening phage display libraries.
Zurita AJ; Arap W; Pasqualini R
J Control Release; 2003 Aug; 91(1-2):183-6. PubMed ID: 12932650
[TBL] [Abstract][Full Text] [Related]
30. Quantitative PCR-based approach for rapid phage display analysis: a foundation for high throughput vascular proteomic profiling.
Ballard VL; Holm JM; Edelberg JM
Physiol Genomics; 2006 Aug; 26(3):202-8. PubMed ID: 16705020
[TBL] [Abstract][Full Text] [Related]
31. Designing scaffolds of peptides for phage display libraries.
Uchiyama F; Tanaka Y; Minari Y; Tokui N
J Biosci Bioeng; 2005 May; 99(5):448-56. PubMed ID: 16233816
[TBL] [Abstract][Full Text] [Related]
32. On the synergistic effects of ligand-mediated and phage-intrinsic properties during in vivo selection.
Driessen WH; Bronk LF; Edwards JK; Proneth B; Souza GR; Decuzzi P; Pasqualini R; Arap W
Adv Genet; 2010; 69():115-33. PubMed ID: 20807605
[TBL] [Abstract][Full Text] [Related]
33. Proteomics in South Africa: current status, challenges and prospects.
Ndimba BK; Thomas LA
Biotechnol J; 2008 Nov; 3(11):1368-74. PubMed ID: 19016510
[TBL] [Abstract][Full Text] [Related]
34. Mucosal vaccination with phage-displayed tumour antigens identified through proteomics-based strategy inhibits the growth and metastasis of 4T1 breast adenocarcinoma.
Shadidi M; Sørensen D; Dybwad A; Furset G; Sioud M
Int J Oncol; 2008 Jan; 32(1):241-7. PubMed ID: 18097564
[TBL] [Abstract][Full Text] [Related]
35. Proteomics in prostate cancer biomarker discovery.
Larkin SE; Zeidan B; Taylor MG; Bickers B; Al-Ruwaili J; Aukim-Hastie C; Townsend PA
Expert Rev Proteomics; 2010 Feb; 7(1):93-102. PubMed ID: 20121479
[TBL] [Abstract][Full Text] [Related]
36. Mapping molecular networks using proteomics: a vision for patient-tailored combination therapy.
Petricoin EF; Bichsel VE; Calvert VS; Espina V; Winters M; Young L; Belluco C; Trock BJ; Lippman M; Fishman DA; Sgroi DC; Munson PJ; Esserman LJ; Liotta LA
J Clin Oncol; 2005 May; 23(15):3614-21. PubMed ID: 15908672
[TBL] [Abstract][Full Text] [Related]
37. Combinatorial ligand-directed lung targeting.
Giordano RJ; Edwards JK; Tuder RM; Arap W; Pasqualini R
Proc Am Thorac Soc; 2009 Aug; 6(5):411-5. PubMed ID: 19687212
[TBL] [Abstract][Full Text] [Related]
38. Translational proteomics: what can you do for true patients?
Belda-Iniesta C; de Castro J; Perona R
J Proteome Res; 2011 Jan; 10(1):101-4. PubMed ID: 20977278
[TBL] [Abstract][Full Text] [Related]
39. [Development of a Drug Discovery Method Targeted to Stromal Tissue].
Kamada H
Yakugaku Zasshi; 2016; 136(3):435-41. PubMed ID: 26935083
[TBL] [Abstract][Full Text] [Related]
40. In vivo phage display and vascular heterogeneity: implications for targeted medicine.
Trepel M; Arap W; Pasqualini R
Curr Opin Chem Biol; 2002 Jun; 6(3):399-404. PubMed ID: 12023122
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
